AI in Clinical Settings: Separating Signal from Noise

There is no shortage of AI products marketed to health systems. From ambient documentation to sepsis prediction, the demos are impressive and the vendor case studies are carefully curated. Deciding what to actually deploy is harder.

Start With the Workflow, Not the Model

The most common mistake is evaluating AI in isolation from the clinical workflow it is supposed to support. A model that achieves 95% accuracy in a research setting can fail quietly in production if:

• The input data is messier than the training set
• Clinicians don't trust the output and override it reflexively
• The alert fires at the wrong point in the workflow to be actionable

Before asking "how good is the model?", ask "what decision does this change, and for whom?"

High-Value, Lower-Risk Entry Points

Some applications have clearer evidence and lower downside risk:

• Ambient documentation: scribes are expensive; AI that drafts notes from recorded encounters saves real time with minimal patient safety exposure
• Prior authorization: largely administrative, rule-bound, and expensive—a good fit for automation
• Radiology triage: routing urgent findings to the top of a queue is a workflow assist, not a replacement for the radiologist

Questions Worth Asking Before Any Deployment

1. What happens when the model is wrong? Is there a human in the loop?
2. How was the model validated, and on whose patient population?
3. Who is accountable when the output contributes to a bad outcome?

AI in clinical settings is not uniquely dangerous compared to other high-stakes industries—but it does require the same rigor applied to drugs and devices. Slow, structured validation beats fast pilots that stall.